Human Bcl-2/pcDNA3 Citations (6)
Originally described in: F16, a mitochondriotoxic compound, triggers apoptosis or necrosis depending on the genetic background of the target carcinoma cell.Fantin VR, Leder P Cancer Res. 2004 Jan 1. 64(1):329-36. PubMed Journal
Articles Citing Human Bcl-2/pcDNA3
| Articles |
|---|
| Quercetin induces protective autophagy and apoptosis through ER stress via the p-STAT3/Bcl-2 axis in ovarian cancer. Liu Y, Gong W, Yang ZY, Zhou XS, Gong C, Zhang TR, Wei X, Ma D, Ye F, Gao QL. Apoptosis. 2017 Apr;22(4):544-557. doi: 10.1007/s10495-016-1334-2. PubMed |
| Profound, durable and MGMT-independent sensitivity of glioblastoma cells to cyclin-dependent kinase inhibition. Le Rhun E, von Achenbach C, Lohmann B, Silginer M, Schneider H, Meetze K, Szabo E, Weller M. Int J Cancer. 2018 Dec 14. doi: 10.1002/ijc.32069. PubMed |
| Alcohol exposure alters pre-mRNA splicing of antiapoptotic Mcl-1L isoform and induces apoptosis in neural progenitors and immature neurons. Donadoni M, Cicalese S, Sarkar DK, Chang SL, Sariyer IK. Cell Death Dis. 2019 Jun 6;10(6):447. doi: 10.1038/s41419-019-1673-3. PubMed |
| Synergistic growth inhibition mediated by dual PI3K/mTOR pathway targeting and genetic or direct pharmacological AKT inhibition in human glioblastoma models. von Achenbach C, Weller M, Kaulich K, Gramatzki D, Zacher A, Fabbro D, Reifenberger G, Szabo E. J Neurochem. 2020 May;153(4):510-524. doi: 10.1111/jnc.14899. Epub 2020 Jan 8. PubMed |
| Interferon-beta sensitizes human glioblastoma cells to the cyclin-dependent kinase inhibitor, TG02. Lohmann B, Le Rhun E, Silginer M, Epskamp M, Weller M. Oncol Lett. 2020 Apr;19(4):2649-2656. doi: 10.3892/ol.2020.11362. Epub 2020 Jan 30. PubMed |
An Inducible T7 Polymerase System for High-Level Protein Expression in Diverse Gram-Negative Bacteria.
Greenwich JL, Alakavuklar MA, Fuqua C.
Microbiol Resour Announc. 2023 Feb 16;12(2):e0111922. doi: 10.1128/mra.01119-22. Epub 2023 Jan 16.
PubMed
Associated Plasmids |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.